Elutia (ELUT) Net Income towards Common Stockholders (2019 - 2026)
Elutia (ELUT) posted Net Income towards Common Stockholders of $425000.0 for Q1 2026, down 97.57% sequentially from $17.5 million in Q4 2025, and up 110.81% YoY from $201607.2 in Q1 2025.
Elutia (ELUT) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends
Elutia has reported Net Income towards Common Stockholders for 8 years, with the latest figure at $425000.0 in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 110.81% year-over-year to $425000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (down 68.01% YoY) and the FY2025 annual result came in at $53380.0, up 198.95% from the prior year.
- Net Income towards Common Stockholders retreated to $425000.0 in Q1 2026 per ELUT's latest filing, from $17.5 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $44.8 million in Q4 2024 and troughed at -$28.2 million in Q2 2024.
- A 5-year average of -$4.4 million and a median of -$8.1 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders soared 447.36% in 2024, then sank 462.51% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$5.4 million in 2022, then sank by 137.26% to -$12.9 million in 2023, then jumped by 447.36% to $44.8 million in 2024, then slumped by 61.05% to $17.5 million in 2025, then plunged by 97.57% to $425000.0 in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $425000.0, $17.5 million, and -$3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Elutia | 40.75 Mn | 20.85 Mn | 1.45 Mn | -7.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 425,000.00 |
| Dec 31, 2025 | 17.46 Mn |
| Sep 30, 2025 | -3.87 Mn |
| Jun 30, 2025 | -9.61 Mn |
| Mar 31, 2025 | -3.93 Mn |
| Dec 31, 2024 | 44.83 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | -28.18 Mn |
| Mar 31, 2024 | -17.99 Mn |
| Dec 31, 2023 | -12.91 Mn |
| Sep 30, 2023 | -9.75 Mn |
| Jun 30, 2023 | -7.73 Mn |
| Mar 31, 2023 | -9.78 Mn |
| Dec 31, 2022 | -5.44 Mn |
| Sep 30, 2022 | -11.03 Mn |
| Jun 30, 2022 | -9.40 Mn |
| Mar 31, 2022 | -8.15 Mn |
| Dec 31, 2021 | -9.06 Mn |
| Sep 30, 2021 | -8.32 Mn |
| Jun 30, 2021 | -2.39 Mn |